Release Date: 01/08/19 09:20 Summary: Quarterly Activities Report and Appendix 4C Price Sensitive: Yes Download Document 571.11KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%